SERIOUS PRE-ECLAMPSY
URGENCY ASSISTANCE ASPECTS
DOI:
https://doi.org/10.37951/2675-5009.2020v1i02.24Keywords:
PRE-ECLAMPSIA, SEVERE, SCREENINGAbstract
Introduction: Preeclampsia (PE) is defined as the appearance, after the twentieth week of gestation, of systemic arterial hypertension (systolic arterial pressure - SBP - greater than or equal to 140 mmHg or Diastolic - DBP - greater than or equal to 90 mmHg as measured in two occasions at 4 hours interval) associated with daily proteinuria above 300 milligrams (mg). The severity of this condition involves the failure of several organs associated with peak pressure and may cause deleterious effects of multiple systems, especially vascular, renal, hepatic and cerebral. Objective: To establish the clinical and epidemiological profile of pregnant women with severe pre-eclampsia. Methods: This is an observational, retrospective, analytical study with patients seen in the emergency room from January to June of 2017, in a total of 12,712. Being selected those with gestational age greater than 20 weeks, presenting hypertensive crisis at the time of hospitalization in the HMDI totaling 81 patients. Results: This group was limited to the study of pregnant women presenting only severe preeclampsia. The number of pregnancies in this group was multiparous with 58% and primipara of 32%. Regarding gestational age, it was of over 20 weeks. Regarding the use of previous home medication 59% did not use any medication. Regarding the clinical picture, 60% did not present imminent signs for preeclampsia. The interruption of pregnancy was prescribed in 51% of the patients, being 68% by cesarean section. They did not perform sulfate in 84% of the patients and in those who were hospitalized also did not perform in 78% of the patients. Conclusion: The frequency of imminent eclampsia within a group of patients with severe preeclampsia was 39.5%. The frequency of sulfate use in patients with severe preeclampsia presented in this study was 16%. The preferred delivery route was cesarean section with 68% and fetal lethality rate was 5%.